{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2022"],"data_sharing_plan":["IPD Sharing (as of July 2023): Undecided"],"condition":["Metastatic Colorectal Cancer","Colon Cancer","Colorectal Neoplasms","Rectal Cancer"],"disease":["Metastatic Colorectal Cancer","Colon Cancer","Colorectal Neoplasms","Rectal Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2746205"],"location":["United States"],"study_start_month":["12"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"A Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer","description":"This study is designed as an open-label, adaptive Simon Two-Stage study to evaluate the efficacy of CTX-009 in patients with metastatic colorectal cancer.\nA Simon Two-Stage adaptive design will enroll approximately 37 patients into Stage 1, and if criteria are met to move to Stage 2, an additional 47 patients will be enrolled.","dates":{"creation":"2022-12-15"},"accession":"2746205","cross_references":{"ClinicalTrials___gov":["NCT05513742"]}}